The purpose of this research study is to describe a patients' fitness before and after treatment (whether that treatment be chemotherapy or a transplant). Fitness is a way of measuring a patient's current quality of health. With surveys, questionnaires and blood tests, we hope to create a tool that will give a good picture of patients' ability to tolerate treatment. In the future, we hope to devise the best treatment for a patient based on their "fitness".
Study Type
OBSERVATIONAL
Enrollment
111
The Ohio State University Hospital East
Columbus, Ohio, United States
Change in Comprehensive Frailty Assessment
Responses to the Comprehensive Frailty Assessment will be assessed before and after treatment and changes will be evaluated. In transplant patients, this will be measured one year post transplant and in the non-transplant arm, this will be assessed after the second cycle of treatment.
Time frame: up to 14 months
Time to progression
We will assess time to progression for multiple myeloma patients and the relationships of those outcomes to patients' functional, cognitive and psychosocial health.
Time frame: date of enrollment to date of documented clinical progression up to two years post-enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.